41 results
Thumbnail

D1.02 - Prevalence of allergic respiratory disorders in urban V/s rural Indian population

Thumbnail

D1.03 - Sustainable and gluten free bread: Are legumes a hidden risk for occupational IgE-mediated respiratory allergy?

Thumbnail

D1.04 - Diagnostic approach for respiratory symptoms linked to microbial contamination in metalworking fluids

Thumbnail

D1.05 - Bet v 6 as a Marker of Pollen Cross-Reactivity in Southern Europe: Insights from a Birch-Free Region

Thumbnail

D1.07 - Profile of sensitization to inhalant allergens in Valencia: Analysis of 1.898 skin prick tests over one year

Thumbnail

D1.09 - Dynamics of pollen allergy in Ukraine during the full-scale invasion shows demand for diagnostics increased with changed sensitization patterns seen

Thumbnail

D1.10 - Tree pollen allergy profile in Ukraine assessed by large-scale molecular component analysis

Thumbnail

D1.11 - Age and Gender Patterns in Fungal Allergen Sensitization: A Study from Central Ukraine

Thumbnail

D1.13 - EHealth tools suitability and technologic innovation use in an Environmental Exposure Chamber

Thumbnail

D1.14 - Molecular Allergy Profiling of Pollen Sensitization in Cluj-Napoca

Thumbnail

D1.15 - Relationship between sensitization to peanuts and tree nuts in children with allergic diseases in a population of the Russian Federation

Thumbnail

D1.12 - Optimal Conventional Diagnostic Approach for Wheat Allergy in Chinese Children

Thumbnail

D2.167 - Effect of Metformin on allergen specific immunotherapy

Thumbnail

D2.169 - Association of Antenatal Corticosteroid Treatment with Risk of Allergic Diseases in Children

Thumbnail

D2.174 - Patient survey to determine the minimal clinically important difference for a combined symptom and medication score in grass AIT

Thumbnail

D2.179 - Evaluation of Sublingual Immunotherapy for Cat Allergy: Results from a Non-Interventional Study

Thumbnail

D2.168 - Systemic reactions to subcutaneous immunotherapy in children

Thumbnail

D2.170 - The placebo effect leads to significantly lower values regarding allergic symptoms and medication use in birch-pollen allergic patients during the birch pollen season

Thumbnail

D2.171 - The individual benefit of subcutaneous immunotherapy with mannan-conjugated birch pollen allergoids is already evident in the first season immediately after treatment

Thumbnail

D2.172 - Subcutaneous immunotherapy with a depigmented cat allergoid in patients with cat allergy is safe and results primarily in delayed local reactions